Tag: Boston Scientific

Embolism Concerns Prompt Boston Scientific To Suspend Watchman FLX Sales In Europe

Boston Scientific halted the sales of its second-generation Watchman FLX in Europe because of higher-than-expected embolism rates. The complication resulted in one death that was linked to postoperative infection after the device was percutaneously removed.

Life April 6, 2016

Court Orders Boston Scientific To Fork Over $100 Million For Transvaginal Mesh Trial

A jury from Delaware adjudged Boston Scientific guilty and ordered it to pay $100 million to 51-year-old Deborah Barba as compensatory and punitive damages.

Life May 29, 2015

FDA Approves Boston Scientific Watchman Afib Heart Device

Boston Scientific's Watchman Left Atrial Appendage Closure (LAAC) Device intends to prevent stroke. It is a non-drug substitute for Warfarin.

Life March 16, 2015

Boston Scientific Forays Into Men's Health With $1.65 Billion Endo Acquisition

Endo International sells its men's health and prostate business to Boston Scientific. The deal is worth $1.65 billion, which is expected to close in the third quarter of this year.

Life March 3, 2015

Boston Scientific, Johnson & Johnson Bury The Hatchet With $600 Million Settlement

Boston Scientific has been in a lot of hot water since it acquired Guidant in 2006. With this settlement, it is finally making peace with Johnson & Johnson and moving on.

Life February 20, 2015

Real Time Analytics